However, the antitumor function of CD4+ T cells in the absence of CD8+ T cells has been reported in several studies, both preclinical and clinical, both for the treatment of primary tumors and rejection of tumor rechallenge in immune mice, in certain situations. Here, CD4 is linked to neoplasm.